{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:51Z","timestamp":1781650671753,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Project of the Medical Technologies Development Program of Nanjing","award":["ZKX21044"],"award-info":[{"award-number":["ZKX21044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Sepsis is a severe condition characterized by life-threatening organ dysfunction resulting from an excessive host response to infection. Among the affected organs, the lungs are particularly susceptible during the progression of sepsis. Tussilagone (TS), a sesquiterpenoid compound derived from the flowers of\n                      <jats:italic>Tussilago farfara<\/jats:italic>\n                      , has been explored for its potential therapeutic effects on sepsis-induced lung injury. This study used both in vitro and in vivo experimental approaches, complemented by network pharmacology analyses, to verify the mechanisms and molecular targets underlying the effects of TS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      TS was administered to mice with sepsis-induced lung injury and to lung epithelial cells stimulated with lipopolysaccharide (LPS) to assess its therapeutic potential. Inflammatory factor levels in mouse serum, lung tissue, and cells were assessed. Western blot analysis was used to determine the expression of NF-\u03baB p65 and MyD88 in lung tissues. Potential molecular TS targets were identified, with receptor-interacting serine\/threonine-protein kinase 1 (\n                      <jats:italic>RIPK1<\/jats:italic>\n                      ) selected for further investigation using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. Additionally, the study explored if TS exerts its protective effects against lung injury in septic mice through targeted regulation of\n                      <jats:italic>RIPK1<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TS inhibited the NF-\u03baB p65 and MyD88 signaling pathways, reducing the release of inflammatory factors and a mitigation of lung injury severity in LPS-induced MLE12 cells and CLP-induced septic mice. Overexpression of RIPK1 protein resulted in elevated expression levels of NF-\u03baB p65 and MyD88, whereas treatment with TS significantly reduced these levels. Similarly, the use of a RIPK1 protein inhibitor to suppress\n                      <jats:italic>RIPK1<\/jats:italic>\n                      expression also decreased the expression of NF-\u03baB p65 and MyD88, further supporting the role of\n                      <jats:italic>RIPK1<\/jats:italic>\n                      in the mechanism of TS-mediated lung protection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      TS demonstrates a protective effect against sepsis-induced acute lung injury (ALI) by inhibiting the expression of\n                      <jats:italic>RIPK1<\/jats:italic>\n                      . These findings indicate that TS can potentially be a therapeutic agent for the treatment of ALI.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00678-7","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:32:03Z","timestamp":1776753123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tussilagone mitigates sepsis-induced acute lung injury in mice by suppressing RIPK1 expression"],"prefix":"10.1186","volume":"163","author":[{"given":"Jie","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"8","key":"678_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"21","key":"678_CR2","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.3390\/ijms20215376","volume":"20","author":"M Huang","year":"2019","unstructured":"Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019;20(21):5376. https:\/\/doi.org\/10.3390\/ijms20215376.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"678_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304\u201377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6.","journal-title":"Intensive Care Med"},{"issue":"9","key":"678_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00134-018-5175-z","volume":"44","author":"CM Coopersmith","year":"2018","unstructured":"Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: research priorities for sepsis and septic shock. Intensive Care Med. 2018;44(9):1400\u201326. https:\/\/doi.org\/10.1007\/s00134-018-5175-z.","journal-title":"Intensive Care Med"},{"issue":"8","key":"678_CR5","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","volume":"46","author":"C Fleischmann-Struzek","year":"2020","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552\u201362. https:\/\/doi.org\/10.1007\/s00134-020-06151-x.","journal-title":"Intensive Care Med"},{"issue":"1","key":"678_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Angus DC. Enhancing Recovery From Sepsis: A Review. JAMA. 2018;319(1):62\u201375. https:\/\/doi.org\/10.1001\/jama.2017.17687.","journal-title":"JAMA"},{"issue":"4","key":"678_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","volume":"104","author":"MD Font","year":"2020","unstructured":"Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020;104(4):573\u201385. https:\/\/doi.org\/10.1016\/j.mcna.2020.02.011.","journal-title":"Med Clin North Am"},{"key":"678_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722","volume":"11","author":"V Kumar","year":"2020","unstructured":"Kumar V. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury. Front Immunol. 2020;11:1722. https:\/\/doi.org\/10.3389\/fimmu.2020.01722.","journal-title":"Front Immunol"},{"key":"678_CR9","doi-asserted-by":"publisher","first-page":"i1585","DOI":"10.1136\/bmj.i1585","volume":"353","author":"JE Gotts","year":"2016","unstructured":"Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. https:\/\/doi.org\/10.1136\/bmj.i1585.","journal-title":"BMJ"},{"issue":"6","key":"678_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1142\/S0192415X20500640","volume":"48","author":"TT Fan","year":"2020","unstructured":"Fan TT, Cheng BL, Fang XM, Chen YC, Su F. Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis. Am J Chin Med. 2020;48(6):1315\u201330. https:\/\/doi.org\/10.1142\/S0192415X20500640.","journal-title":"Am J Chin Med"},{"key":"678_CR11","doi-asserted-by":"publisher","unstructured":"Kim YK, Yeo MG, Oh BK, Kim HY, Yang HJ, Cho SS, Gil M, Lee KJ. Tussilagone Inhibits the Inflammatory Response and Improves Survival in CLP-Induced Septic Mice. Int J Mol Sci. 2017;18(12):2744. https:\/\/doi.org\/10.3390\/ijms18122744. Erratum in: Int J Mol Sci. 2019;21(1): PMID: 29258263; PMCID: PMC5751343.","DOI":"10.3390\/ijms18122744"},{"key":"678_CR12","doi-asserted-by":"publisher","first-page":"12780","DOI":"10.3390\/ijms140612780","volume":"14","author":"M Chadwick","year":"2013","unstructured":"Chadwick M, Trewin H, Gawthrop F, Wagstaff C. Sesquiterpenoids lactones: Benefits to plants and people. Int J Mol Sci. 2013;14:12780\u2013805.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"678_CR13","first-page":"1767","volume":"10","author":"C Rde","year":"2015","unstructured":"da Silveira e S\u00e1, Rde C, Andrade LN, de Sousa DP. Sesquiterpenes from Essential Oils and Anti-Inflammatory Activity. Nat Prod Commun. 2015;10(10):1767\u201374.","journal-title":"Nat Prod Commun"},{"issue":"1","key":"678_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jep.2011.12.027","volume":"140","author":"ZY Li","year":"2012","unstructured":"Li ZY, Zhi HJ, Xue SY, Sun HF, Zhang FS, Jia JP, Xing J, Zhang LZ, Qin XM. Metabolomic profiling of the flower bud and rachis of Tussilago farfara with antitussive and expectorant effects on mice. J Ethnopharmacol. 2012;140(1):83\u201390. https:\/\/doi.org\/10.1016\/j.jep.2011.12.027.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"678_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3109\/14756366.2014.965701","volume":"30","author":"HJ Lim","year":"2015","unstructured":"Lim HJ, Dong GZ, Lee HJ, Ryu JH. In vitro neuroprotective activity of sesquiterpenoids from the flower buds of Tussilago farfara. J Enzyme Inhib Med Chem. 2015;30(5):852\u20136. https:\/\/doi.org\/10.3109\/14756366.2014.965701.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"678_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2013.11.062","volume":"443","author":"H Li","year":"2014","unstructured":"Li H, Lee HJ, Ahn YH, Kwon HJ, Jang CY, Kim WY, Ryu JH. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of \u03b2-catenin. Biochem Biophys Res Commun. 2014;443(1):132\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2013.11.062.","journal-title":"Biochem Biophys Res Commun"},{"key":"678_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.intimp.2016.02.026","volume":"34","author":"J Lee","year":"2016","unstructured":"Lee J, Kang U, Seo EK, Kim YS. Heme oxygenase-1-mediated anti-inflammatory effects of tussilagonone on macrophages and 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation in mice. Int Immunopharmacol. 2016;34:155\u201364.","journal-title":"Int Immunopharmacol"},{"key":"678_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689\u201397. https:\/\/doi.org\/10.1038\/ni.3206.","journal-title":"Nat Immunol"},{"key":"678_CR19","unstructured":"RIPK protein kinase. family: atypical lives of typical kinases. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2020.06.014. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1084952119302447. Published online July 27, 2020."},{"issue":"1","key":"678_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminformatics. 2014;6(1):1\u20136.","journal-title":"J Cheminformatics"},{"key":"678_CR21","doi-asserted-by":"publisher","unstructured":"Pang SJ et al. RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKK\u03b2\/NF-\u03baB signaling during sepsis.2025;23(1):274. https:\/\/doi.org\/10.1186\/s12964-025-02278-w.","DOI":"10.1186\/s12964-025-02278-w"},{"key":"678_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2018.08.022","volume":"294","author":"HJ Cheon","year":"2018","unstructured":"Cheon HJ, Nam SH, Kim JK. Tussilagone, a major active component in Tussilago farfara, ameliorates inflammatory responses in dextran sulphate sodium-induced murine colitis. Chem Biol Interact. 2018;294:74\u201380. https:\/\/doi.org\/10.1016\/j.cbi.2018.08.022.","journal-title":"Chem Biol Interact"},{"key":"678_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fcell.2019.00108","volume":"7","author":"C Nedeva","year":"2019","unstructured":"Nedeva C, Menassa J, Puthalakath H. Sepsis: inflammation is a necessary evil. Front Cell Dev Biol. 2019;7:108. https:\/\/doi.org\/10.3389\/fcell.2019.00108.","journal-title":"Front Cell Dev Biol"},{"key":"678_CR24","doi-asserted-by":"publisher","unstructured":"Prochnicki T, Mangan MS, Latz E. Recent insights into the molecular mechanisms of the nlrp3 inflammasome activation. F1000Res. 2016;5. https:\/\/doi.org\/10.12688\/f1000research.8614.1.","DOI":"10.12688\/f1000research.8614.1"},{"issue":"13\u201314","key":"678_CR25","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.intimp.2009.09.016","volume":"9","author":"C Hwangbo","year":"2009","unstructured":"Hwangbo C, Lee HS, Park J, Choe J, Lee JH. The anti-inflammatory effect of tussilagone, from tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages. Int Immunopharmacol. 2009;9(13\u201314):1578\u201384. https:\/\/doi.org\/10.1016\/j.intimp.2009.09.016.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"678_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.intimp.2014.07.023","volume":"22","author":"Y Park","year":"2014","unstructured":"Park Y, Ryu HS, Lee HK, Kim JS, Yun J, Kang JS, et al. Tussilagone inhibits dendritic cell functions via induction of heme oxygenase-1. Int Immunopharmacol. 2014;22(2):400\u201308. https:\/\/doi.org\/10.1016\/j.intimp.2014.07.023.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"678_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/tox.23476","volume":"37","author":"H Lin","year":"2022","unstructured":"Lin H, Chen M, Gao Y, Wang Z, Jin F. Tussilagone protects acute lung injury from pm2.5 via alleviating hif-1alpha\/nf-kappab-mediated inflammatory response. Environ Toxicol. 2022;37(5):1198\u2013210. https:\/\/doi.org\/10.1002\/tox.23476.","journal-title":"Environ Toxicol"},{"issue":"4","key":"678_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","volume":"47","author":"I Tabas","year":"2017","unstructured":"Tabas I, Lichtman AH. Monocyte-Macrophages and T Cells in Atherosclerosis. Immunity. 2017;47(4):621\u201334. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.008.","journal-title":"Immunity"},{"issue":"2","key":"678_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.118.038379","volume":"143","author":"D Karunakaran","year":"2021","unstructured":"Karunakaran D, Nguyen MA, Geoffrion M, et al. RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-\u03baB Activation and Atherogenesis in Mice. Circulation. 2021;143(2):163\u201377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038379.","journal-title":"Circulation"},{"key":"678_CR30","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00018-016-2191-4","volume":"73","author":"Y Dondelinger","year":"2016","unstructured":"Dondelinger Y, Darding M, Bertrand MJ, Walczak H. Poly-ubiquitination in TNFR1-mediated necroptosis. Cell Mol Life Sci. 2016;73:2165\u201376. https:\/\/doi.org\/10.1007\/s00018-016-2191-4.","journal-title":"Cell Mol Life Sci"},{"key":"678_CR31","doi-asserted-by":"publisher","first-page":"e76841","DOI":"10.1371\/journal.pone.0076841","volume":"8","author":"DM Moquin","year":"2013","unstructured":"Moquin DM, McQuade T, Chan FK. CYLD deubiquitinates RIP1 in the TNF\u03b1-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS ONE. 2013;8:e76841. https:\/\/doi.org\/10.1371\/journal.pone.0076841.","journal-title":"PLoS ONE"},{"issue":"4","key":"678_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4049\/jimmunol.1400590","volume":"193","author":"A Polykratis","year":"2014","unstructured":"Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van TM, et al. Cutting edge: ripk1 kinase inactive mice are viable and protected from tnf-induced necroptosis in vivo. J Immunol. 2014;193(4):1539\u201343. https:\/\/doi.org\/10.4049\/jimmunol.1400590.","journal-title":"J Immunol"},{"key":"678_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.02.017","author":"AC Bolognese","year":"2018","unstructured":"Bolognese AC, Yang WL, Hansen LW, Denning NL, Nicastro JM, Coppa GF, et al. Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis. Surgery. 2018. https:\/\/doi.org\/10.1016\/j.surg.2018.02.017.","journal-title":"Surgery"},{"issue":"1","key":"678_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41419-020-03365-1","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xu Q, Wang Y, Liang T, Li X, Wang D, et al. Necroptosis is active and contributes to intestinal injury in a piglet model with lipopolysaccharide challenge. Cell Death Dis. 2021;12(1):62. https:\/\/doi.org\/10.1038\/s41419-020-03365-1.","journal-title":"Cell Death Dis"},{"issue":"6","key":"678_CR35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41418-018-0215-3","volume":"26","author":"Z Su","year":"2019","unstructured":"Su Z, Dziedzic SA, Hu D, Barrett VJ, Broekema N, Li W, et al. Abin-1 heterozygosity sensitizes to innate immune response in both ripk1-dependent and ripk1-independent manner. Cell Death Differ. 2019;26(6):1077\u201388. https:\/\/doi.org\/10.1038\/s41418-018-0215-3.","journal-title":"Cell Death Differ"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00678-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:28:05Z","timestamp":1781648885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00678-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00678-7","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were evaluated and approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (IACUC-14349) and complied with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}